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Background. Tissue damage at the time of organ transplan-
tation has a negative impact on the subsequent success of the
procedure, both in the immediate and longer term. Hypother-
mia is the principal element used to prolong organ viability
ex vivo, but paradoxically also induces cellular edema through
inhibition of energy-dependent adenosine triphosphatases
(ATPases). This induces an electrolyte imbalance that leads to
fluid influx and cell swelling. It is important, therefore, that im-
provements are made in the preservation of ischemic organs to
reduce this injury.
Methods. This study has applied a novel in vitro system to
model cold and warm ischemic-induced renal tubule swelling
that characterizes tissue damage in ischemia/reperfusion injury.
Biochemical blockade of ATPases in this system using stro-
phanthidin modeled the effects of energy depletion and induced
cell swelling. By measuring such tubule swelling and changes to
tubular cell volume in isolated rabbit renal proximal tubules, an
analysis was made that defined the basis on which an optimal
preservation solution may be developed.
Results. The data show that our model could reproduce
ischemically induced cell swelling and characterized the re-
sponse at the cellular level of tubules to different components
of preservation solutions. The data indicate that an isosmolar,
phosphate-buffered, sucrose solution prevented tubule swelling
more effectively than Euro-Collins, hyperosmolar citrate, or
University of Wisconsin solutions that are in routine clinical
use.
Conclusion. Future developments in organ preservation may
significantly improve transplant outcomes. Our novel analysis
forms the basis of future whole-organ studies that ultimately
may allow us to propose an optimum platform for improved
preservation solutions.
The process of organ procurement and implantation
constitutes a severe physical stress on solid organs used
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in transplantation. Despite major advances in organ
transplantation, surgical technique, transplant immunol-
ogy, preservation techniques, and preservation solutions,
every transplant organ faces two inevitable insults—
ischemia and subsequent reperfusion. A period of cold
ischemia extends from the time of organ procurement to
the time when it is removed from cold storage just before
implantation. This is followed by a shorter but potentially
more hazardous period of warm ischemia during implan-
tation. The final physical stress is that of reperfusion of
the organ with recipient blood, the so-called reperfusion
injury.
To minimize the effects of organ damage and is-
chemia/reperfusion (I/R) injury, but also to allow time for
organ allocation, organ transportation and surgery, organ
procurement requires both in situ flush with a cold preser-
vation solution, and hypothermic storage at 0 to 4◦C.
During ischemia, active transport mechanisms involving
Na+/K+ and Ca2+/Mg2+ adenosine triphosphatase (AT-
Pase) are inhibited [1], which leads to a steady influx of
Na+, Cl−, and Ca2+ into the cell with subsequent osmotic
influx of water causing cellular swelling. Hypothermia
reduces the rate of tissue damage by depressing the cel-
lular metabolism, but although it forms the central com-
ponent of any organ preservation strategy, hypothermia
also directly contributes to cellular edema by direct de-
pressant effects on ATPase-dependent active transport
mechanisms [1].
Ischemia also results in lowered pH and an accumu-
lation of toxic products of anaerobic respiration (e.g.,
lactate and hypoxanthine) that contribute to free radi-
cal damage upon reperfusion of the organ with recipient
blood [2, 3]. It is well known that severe I/R injury leads to
delayed graft function (DGF) posttransplant [4]. These
authors have quoted a 5% incidence of DGF for liver,
and a 20% to 30% DGF for renal transplantation, while
United Kingdom Transplant reported a 19% incidence of
DGF in UK adult cadaveric renal transplantation nation-
wide over 5 years to 2002 (UKT, Bristol, UK, personal
communication). Such DGF has been linked to poorer
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Table 1. Constituents of preservation solutions used in this study
Hyperosmolar Phosphate-buffered University of
Components mmol/L Euro-Collins citrate sucrose 140 Wisconsin
Glucose 194
Mannitol 186
Sucrose 140
Raffinose 30
Lactobionic acid 105
HES % 5
Phosphate
Na2HPO4 42.3
NaH2PO4.2H2O 26.7
K2HPO4 32.2
KH2PO4 15 25
NaHCO3 10
NaOH 27
KOH 100
Citrate 54
Na+ 3-citrate 28
K+ 3-citrate 26
KCl 15
MgSO4 41 5
Glutathione 3
Allopurinol 1
Adenosine 5
Insulin IU 40
Penicillin G IU 200,000
Dexamethasone mg 16
Osmolality mOsm.kg−1 355 400 300 325
pH 7.0 7.1 7.0 7.4
prognosis [5, 6]. In a clinical study, one- and five-year
graft survival was significantly reduced from 95% and
81% in early functioning grafts to 87% and 70% in de-
layed functioning grafts, respectively. In addition, a link
was established between DGF and the incidence of acute
rejection that negatively impacted upon graft half-life [7].
The effects of I/R injury and the subsequent tissue dam-
age that manifests as DGF may render the organ more
visible to the immune system of the recipient and promote
activation of both innate and adaptive immunity against
the donor organ [8, 9]. In particular, lipid peroxidation
will lead not only to membrane damage and activation
of arachidonic acid pathways with subsequent release of
prostaglandins and leukotrienes, but may also increase
tissue susceptibility to complement activation through
the alternative pathway [10]. Such proinflammatory me-
diators will stimulate not only the release of cytokines
and chemokines by damaged tissue, but also contribute
to an acute-phase response that further promotes inflam-
mation. Recent experimental studies have demonstrated
that long-term outcomes may well be affected by tissue
damage induced as a result of less than optimal ischemia
and that modifications to preservation solutions can sig-
nificantly improve organ function [11].
The core components of any preservation solution are
impermeant agents that prevent fluid entry into cells,
buffers that maintain pH, and ions (Table 1). Secondary
components may confer additional benefits but are not
essential for organ preservation. These include free radi-
cal scavengers, calcium antagonists, colloids, complement
regulators, and antiplatelet agents. Solutions such as hy-
perosmolar citrate (HOC) also use a hypertonicity of 400
mOsm in a bid to prevent fluid entry into cells whose
isotonic environment is approximately 285 to 300 mOsm.
Currently used buffer systems include phosphate, cit-
rate, histidine, and bicarbonate. Preservation solutions,
with the exception of University of Wisconsin (UW;
pH 7.4), commonly have an acidic pH (6.9 to 7.1) in
relation to plasma. This followed work which indicated
that an acidic pH may actually protect against hypoxic
injury [12–14]. The inclusion of high potassium in the
preservation media has been thought to be important in
preventing potassium loss during cold storage [15, 16].
It is also thought that a high potassium concentration
helps to prevent the build up of intracellular calcium
during ischemia. Euro-Collins (EC), hyperosmolar cit-
rate (HOC), and UW solutions have a high potassium
content and are thus classed as “intracellular” solutions.
Phosphate-buffered sucrose (PBS140), developed by
Andrews and Coffey [17] for morphologic preservation
of kidney tubules, however, contains only sodium and
no potassium and is thus classed as an “extracellular”
solution.
The cellular edema caused by the influx of water is the
primary pathophysiologic event that affects ischemic or-
gans. In the kidney, it is the corticomedullary segments
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of renal tubules that appear most vulnerable to I/R in-
jury [18]. This compartmental susceptibility is possibly
explained by the no-reflow phenomenon whereby severe
edema constricts blood vessels and limits delivery of oxy-
gen on reperfusion of affected tissues [19]. Tubule cell
volume is actively regulated in vivo but this regulation
is lost in the ischemic tissue since the process is energy
dependent and ATP is almost totally depleted in an is-
chemic organ within 4 hours of ischemia [20]. The aims of
this study were to develop a new in vitro system to model
the effect of ischemia on tubule cell swelling, and to an-
alyze the effect of preservation solutions and their core
components in preventing this tissue damage. Following
from this study, new recommendations are made for the
basic constitution of an optimized preservation solution,
specifically to address tubule cell edema. This forms the
principal pathologic insult to whole organs, and preven-
tion of such cell swelling could have significant benefit for
transplant outcome if improved solutions are adopted by
transplant centers.
METHODS
Animals and anesthesia
Specific pathogen-free (SPF), New Zealand White
(NZW) rabbits 1.5 to 2.5 kg in weight were used through-
out the experiments (Charles River, Surrey, UK). United
Kingdom Home Office Guidelines (Scientific Procedures
Act, 1986) were strictly adhered to throughout this work.
Terminal anesthesia was induced by intravenous pento-
barbitone 60 mg·kg−1 (Sagattal, RMB Animal Health
Limited, Dagenham, UK).
Experimental plan
In brief, isolated rabbit kidneys were perfused in situ
with a preservation fluid under test and maintained on ice
for varied cold ischemic times. Following this, single prox-
imal tubules were micro-dissected from the renal cortex
and assessed for tubule swelling as a result of cold is-
chemia, and during a period of warm ischemia using the
protocol described below.
Perfusion of kidneys
A 50 mL syringe reservoir was set at a height of 50 cm
above the table and was filled with 40 mL of cold preser-
vation solution (0 to 4◦C) just prior to the flush. A wide
bore polyvinyl tubing (2 mm internal diameter) was con-
nected to the reservoir. The draining end was tapered
for cannulation of the aorta or the renal artery. The tip
of the catheter was also barbed with a scalpel blade to
avoid the ligature slipping. A midline incision was made
and a laparotomy performed. The lower abdominal aorta
was ligated above the iliac bifurcation with a 3/0 silk tie
(Ethicon Limited, Edinburgh, UK) followed by ligation
of the aorta below the origin of the celiac trunk but above
the origin of both renal arteries. An incision was made in
the aorta above the lower tie, and with the flush solu-
tion running a catheter was introduced through this in-
cision. The catheter was then secured with a 3/0 silk tie.
Blood was drained by venting the inferior vena cava in
the chest. The warm ischemia time of the whole proce-
dure was less than 1 minute. After 25 mL flush solution
had passed through, the kidneys were excised and placed
in glass beakers containing 100 mL of the preservation
fluid under test on ice. These were then stored in the re-
frigerator at 4◦C for a period dictated by the protocol of
the experiment.
Dissection of proximal tubules
After a defined period of storage (0, 24, 48, or 72 hours,
according to the experimental protocol) the kidney was
removed and the capsule was carefully stripped using fine
forceps and dissection scissors. A thin (approximately
0.5 mm thick) cross-section slice was cut with a scalpel
blade and placed in a Petri dish half filled with the preser-
vation solution under test. The Petri dish was placed
on a refrigerated metal dissecting surface of a purpose
built dissecting table (Conair Refrigerator Circulator,
Warrington, UK) under a stereoscopic zoom microscope
(Nikon SMZ-2) mounted directly above the Petri dish. A
servo-driven focusing mount controlled by a foot pedal
left both hands free for dissection. At ×800 magnifica-
tion various segments of nephron can be identified. They
appear translucent-gold in color against the black back-
ground. Both proximal and distal tubules have a typical
convoluted appearance and are readily identifiable within
the outer cortex. The early S1 and S2 segments of the prox-
imal tubules can be identified due to their convoluted
nature and the attachment of the S1 segment to the
glomerulus by a narrow neck. In contrast, the proximal
straight tubules have no convolutions and have a typical
“ground glass” appearance. The cortical collecting duct
is also straight and has a small diameter and an indistinct
image. The thin loop of Henle is the smallest in diam-
eter and is mostly confined to the medulla, as are the
medullary collecting ducts, which are easily identified as
tightly packed straight tubules in the medulla. The thick
ascending limb of loop of Henle is difficult to differenti-
ate from the cortical collecting ducts (CCD). However, it
does not have the less defined appearance of CCD under
high magnification. Cortical S1 and S2 segments of proxi-
mal tubules were used for these experiments. Two pairs of
micro-fine forceps (Thackray, Leeds, UK) and a 23 G nee-
dle mounted on a 1 mL syringe were used for dissection.
The cortical tissue was gently teased apart until a tubule
was seen bridging the gap or hanging freely at the edge
between two tissue pieces. Finally, the ends were cleanly
cut by the sharp edge of the mounted needle acting as a
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micro-blade. A transfer pipette was used to transfer the
single dissected tubule to the perfusion bath. The transfer
pipette consisted of a Pasteur pipette with the distal 1.5
to 2.0 cm bent at right angle. The bulb was controlled by
an adjustable screw which allowed fluid to be drawn up
and ejected. Before transferring the tubules, the inside of
the pipette tip was coated with dilute albumin solution
(5 mL of bovine 25% albumin solution in Tyrode’s buffer
dissolved in 25 mL of saline) to prevent the tubules from
sticking to the pipette glass.
The microperfusion rig
A standard inverted microscope (e.g., ×2.7, ×4, ×10,
and ×20 objectives and a ×20 eyepiece) was used in these
experiments. The perfusion bath (J. White, MD, Wash-
ington, USA) consisted of a circular 0.5 cm thick acrylic
plate. A longitudinal 2.0 × 0.5 cm full thickness slot was
cut in the center and formed the walls of the perfusion
bath while a glass cover slip stuck to the base with melted
wax formed the floor of the bath. The chamber held 1 cm
depth of bathing fluid. There were multiple inlets into the
chamber to allow experimental manipulations and mon-
itoring (temperature, pH, etc.).
Experimental reperfusion protocol
Tubules were then set up on an inverted microscope
and the tubule diameter was measured at 5-minute
intervals using an eyepiece graticule (Graticules Ltd.,
Tonbridge, Kent, UK). The graticule was calibrated
against a standard scale under various magnifications.
This form of analysis was validated against later measure-
ments using a photodiode array [21] and found to be ac-
curate and reproducible. For the period of measurement,
the tubules were initially bathed in oxygenated physio-
logic saline for 10 minutes, during which time the cell size
equilibrated and reached a steady volume. The bathing
fluid was then replaced by either physiologic saline or a
test preservation solution with or without strophanthidin.
This test period lasted for 35 minutes and was related to
the warm ischemia of transplantation. Finally, the bathing
fluid was again replaced by oxygenated physiologic saline,
allowing the cells to recover. This second period in saline
lasted for 25 minutes and paralleled reperfusion in trans-
plantation while also acting as a second control period.
Strophanthidin treatment of isolated tubules
Strophanthidin (5b ,20[22]-Cardenoline-19-one-3b ,5,
14-triol) is a 405 kD cardiac glycoside derivative of digi-
talis and is related to digoxin and ouabain in its properties.
Strophanthidin is a selective inhibitor of Na+/K+ ATPase,
and competes with K+ for Na+/K+ ATPase receptors
[22]. In cardiac myocytes, strophanthidin exerts a posi-
tive inotropic effect similar to that of digoxin. The rise in
intracellular sodium with strophanthidin treatment is due
to suppressed sodium extrusion via the Na+/K+ ATPase
pump, and activated sodium influx via Na+/H+ exchange
[23]. Specific sodium channel blockers (e.g., SUN1165),
therefore, partly abolish the rise in intracellular sodium
resulting from use of strophanthidin and digoxin [24].
Tubules prepared as described above were incubated with
doses of strophanthidin as indicated. At concentrations
greater than 10−3 mol/L, the solubility of strophanthidin
was a limiting factor. For all test experiments a dose of
10−3 mol/L was applied.
Calculation of tubule cell volume
At 37◦C fluids and solutes in the tubular lumen are
pumped out across the basolateral membrane causing
the tubular lumen to collapse. The outside diameter of
a collapsed tubule (two rows of cells) can thus be used
to calculate cell volume mathematically (ql.mm−1) with
the equation p r2 × l, or 3.1416 × (Tubule diameter/4)2 ×
1000.
Statistics
Data were analyzed using Student t test or repeated
measures analysis of variance as appropriate. P < 0.05
was considered to be significant. For each solution un-
der test, tubules from 6 separate kidneys from 6 differ-
ent animals were used for each time point of analysis
(N = 6).
RESULTS
Isolated tubule segments were prepared and exposed
to different preservation solutions in order to examine
cell swelling in a situation that paralleled ischemia. In all
experiments tubule diameter was measured across the
midpoint of the tubule segment (Fig. 1).
Evaluation of impermeants in organ preservation
Proximal tubules were prepared as per protocol and,
following an initial equilibration period in physiologic
saline, maintained in preservation solutions at 37◦C
that contained different impermeants (Table 2). Results
were grouped into three categories: monosaccharides
(Fig. 2A), disaccharides (Fig. 2B), and trisaccharides and
anions (Fig. 2C). Impermeants currently used in preser-
vation solutions were then compared as a group (Fig. 2D).
This comparison showed that mannitol performed better
in preventing ischemic induced cell swelling than either
glucose, fructose or mannose (P < 0.001). Although the
disaccharides and trisaccharide prevented cell swelling
to some degree in comparison to the monosaccharides,
within this group sucrose and raffinose were most ef-
fective. Addition of anions in the form of gluconate
or lactobionate (at concentrations given in Table 2)
demonstrated that lactobionate was more effective as an
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Fig. 1. Photograph of a normal unperfused rabbit proximal tubule (A) (×200) and a swollen tubule (B) (×200) after prolonged ischemia. (C and
D) illustrate the midpoint measurement at higher magnification (×700) of the normal (C) and swollen tubules (D) shown in the inserts.
impermeant (P < 0.001) than gluconate. By direct com-
parison of the effect of impermeants used in standard
solutions (Fig. 2D), sucrose performed as well as raffi-
nose (UW) with no significant difference between the
two in this analysis (P > 0.05), and significantly better
than lactobionate, glucose (EC) or mannitol (HOC) (P <
0.005). From these experiments it appeared that the dis-
accharide sucrose was as effective in the prevention of
cell swelling as the trisaccharide raffinose and the anion
lactobionate used in UW. Sucrose was significantly more
effective an impermeant than glucose or mannitol, used
in EC and HOC, respectively.
The use of strophanthidin to mimic warm
ischemic-induced cell swelling
To investigate the effect of strophanthidin on cell vol-
ume a dose titration of this agent was applied to isolated
rabbit proximal convoluted renal tubules and demon-
strated increased cell swelling as a result of Na+/K+
pump blockade in a dose and time-dependent manner
82 Ahmad et al: Ischemia-induced renal tubule cell edema
Table 2. Test preservation solutions using various “impermeant” molecules
Phosphate-buffered
Impermeant concentration mmol/L−1concentration Osmolality
Solutions Impermeant mmol/L−1 Na2 HPO4 NaH2PO4 pH mOsm·L−1
PBG Glucose 140 42.3 26.7 7.0 300
PBF Fructose 140 42.3 26.7 7.0 300
PBMntl Mannitol 140 42.3 26.7 7.0 300
PBMnse Mannose 140 42.3 26.7 7.0 300
PBS140 Sucrose 140 42.3 26.7 7.0 300
PBT Trehalose 140 42.3 26.7 7.0 300
PBMlts Maltose 140 42.3 26.7 7.0 300
PBR Raffinose 140 42.3 26.7 7.0 300
PBL Lactobionatea 140 9.26 5.83 7.0 300
PBGcnt Gluconatea 140 9.26 5.83 7.0 300
Abbreviations are: PBG, phosphate-buffered glucose; PBF, phosphate-buffered fructose; PBMntl, phosphate buffered mannitol; PBMnse, phosphate-buffered
mannose, PBS140, phosphate-buffered sucrose; PBT, phosphate-buffered trehalose; PBMlts, phosphate-buffered maltose; PBR, phosphate-buffered raffinose; PBL,
phosphate-buffered lactobionate; PBGcnt, phosphate-buffered gluconate.
Postfix after phosphate buffer indicates the sugar/anion molecules.
aSodium salt used, phosphate concentration reduced.
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Fig. 2. Comparison of impermeants showed that of the monosacharrides (A), mannitol prevented ischemic induced cell swelling significantly better
than either glucose, fructose or mannose (P< 0.001). Within the disaccharides and trisaccharides (B), sucrose and raffinose were most effective. Of
the anions (C), lactobionate was more effective as an impermeant than gluconate (P < 0.001). By direct comparison of the effect of impermeants
used in standard solutions (D), sucrose performed as well as raffinose [used in University of Wisconsin solution (UW)] with no significant difference
between the two in this analysis (P > 0.05).
(Fig. 3A). Such cell swelling was shown to be rapidly
reversible by the flushed removal of strophanthidin
(Fig. 3B) such that tubules returned to their normal di-
ameter pre-strophanthidin. This protocol therefore ap-
peared to mimic the warm ischemic-induced tubule cell
swelling that was more severe after 24 hours cold is-
chemia. In vitro blocking of the Na+/K+ pump appeared
to create a similar situation that was alleviated by removal
of the agent. Therefore, strophanthidin was used to in-
duce biochemical cell swelling of rabbit proximal convo-
luted renal tubules to model warm ischemia. This model
was used to test the effectiveness of various preservation
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Fig. 3. A dose titration of strophanthidin demonstrated dose-dependent increase in cell swelling with increasing pump blockade (A). To test the
reversibility of strophanthidin-induced cell swelling, tubules were exposed to various periods of cold ischemia, which resulted in an increase in the
response to strophanthidin-induced warm ischemic pump blockade (B). The influence of cold ischemia also manifested as an increased cell size
even after strophanthidin was washed out of the system.
solutions against the hypothesis that such solutions pre-
vent cell swelling that occurs under ischemic conditions
because of metabolic inhibition of the Na+/K+ pump
transporter.
Assessment of impermeants in HOC and EC
The data showed that sucrose acted as the most ef-
fective impermeant during experimental ischemia. In
order to establish the efficacy of the impermeants of
the most commonly used renal preservation solutions
EC and HOC, glucose and mannitol, respectively, were
exchanged for sucrose. Strophanthidin blockade was
applied in order to assess cell swelling during the warm
ischemic phase (Fig. 4A to D). The data showed that cell
swelling was significantly reduced in tubules preserved
in EC containing sucrose instead of glucose following 0
(Fig. 4A, P < 0.001) or 24 hours (Fig. 4B, P < 0.001) of cold
ischemia. However, improved preservation of HOC by
using sucrose instead of mannitol was only evident after
24 hours of cold storage (Fig. 4C and D, P < 0.05). From
our data it was apparent that sucrose provides superior
protection from cell swelling over glucose or mannitol.
Further assessment of modifications to HOC
Since HOC is the most commonly used kidney preser-
vation solution in the United Kingdom, a further analysis
of HOC was made. Osmolality has a critical impact upon
fluid dynamics within cells and tissues. When the osmo-
lality of HOC was reduced from 400 to 300 mOsm·kg−1
[isosmolar citrate (IOC)] our data showed minimal im-
pact at time 0 (P > 0.05), but significant improvement
(P < 0.05) after 24 hours cold ischemia as compared with
tubules exposed to normally constituted HOC (Fig. 5A
and B). The addition of MgSO4 to Collins original preser-
vation solution was a beneficial development. To establish
the requirement for MgSO4 in HOC a comparison was
made using HOC in the experimental analysis of tubule
cell edema (Fig. 5C and D). The data showed that there
was no difference in cell swelling between these groups.
In the third modification, sodium and potassium citrate
buffer of HOC was replaced by a sodium and potassium
phosphate, while maintaining the pH at 7.1 and the osmo-
lality at 400 mOsm·kg−1. MgSO4 was also replaced with
an equivalent amount of mannitol as it tends to form
a precipitate with phosphate. The data showed that re-
placement of a citrate-based buffer in HOC with a phos-
phate buffer had no immediate effects on the ischemic-
induced cell swelling at time 0 (Fig. 5E, P > 0.05), but after
24 hours cold ischemic time, significant improvement was
noted (Fig. 5F, P < 0.05).
Comparison of an optimized solution with commercially
available preservation solutions
The data derived from the above experiments sug-
gested that a phosphate-buffered, isosmolar, sucrose
solution would combine the best characteristics for a re-
nal preservation solution that would prevent proximal
tubular cell swelling over prolonged periods of cold is-
chemia. Such a solution (PBS140) was applied to the
strophanthidin-based isolated proximal tubule experi-
ments, and compared against the ability of EC, HOC,
and UW solutions to control cell volume during warm is-
chemia. The data showed that PBS140 was as good as UW
in preventing cell swelling (Fig. 6A). The experiment was
repeated on tubules rendered cold ischemic for 24, 48,
and 72 hours in order to establish effects of solutions on
increasingly severe ischemic injury. Here results showed
that PBS140 was comparable if not better in reducing cell
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Fig. 4. Sucrose was added to Euro-Collins (EC) as a replacement for glucose (A) and showed a highly significant improvement in tubule preservation
(P< 0.001). After 24 hours of cold ischemia (B), replacing glucose with sucrose in EC further demonstrated the efficacy of sucrose as an impermeant
(P < 0.001). Without any prolonged cold ischemia, replacing the impermeant mannitol in hyperosmolar citrate (HOC) with sucrose (C) had no
statistically significant effect on cell swelling after strophanthidin-induced pump blockade. After 24 hours of cold ischemia (D), sucrose provided
significant protection when it replaced mannitol in HOC (P < 0.05).
swelling than any of the commercially available solutions,
including UW (Fig. 6B to D).
Cell volume changes following cold and warm ischemia
with current preservation solutions
By analyzing pre- and post-warm ischemic cell volumes
(pl.mm−1) over 0, 24, 48, and 72 hours of cold ischemia,
it was evident that at the earliest time points EC failed
to prevent cell swelling that was further increased after
warm ischemia (Fig. 7A). Similar analysis showed that us-
ing HOC (Fig. 7B) prevented the early cell swelling that
was exhibited by tubules preserved in EC but did little
to reduce warm ischemic cell swelling. After prolonged
periods of cold ischemia a time dependent increase in
cell volume was shown and susceptibility to warm is-
chemia was maintained in the presence of HOC. The use
of UW (Fig. 7C) prevented to some degree the cold in-
duced cell swelling but an increase in the response of
tubules to warm ischemia was seen with increasing dura-
tion of cold ischemia. However, using PBS140 (Fig. 7D)
effectively reduced the susceptibility of tubules to cold
ischemia over 72 hours and reduced the subsequent cell
volume response upon exposure to warm ischemia even
after 72 hours of cold ischemia. In this analysis PBS140
demonstrated its capacity to prevent cell swelling more
effectively than UW.
From these data it is evident that, following strophan-
thidin blockade, both PBS140 and UW show the least
percentage increase in cell volume after CIT 0 (+10 and
+8% respectively), when compared to the 30% increase
of EC and 36% increase of HOC. It also appears that the
starting cell volume after cold ischemia was lowest for
PBS140 and highest for EC (Table 3). After a prolonged
cold ischemic insult of 72 hours, PBS140 proved to be
the most effective of the preservation solutions in pre-
venting warm ischemic tubular edema. Here a minimal
increase in cell volume of 7% was observed compared to
23%, 38%, and 25% for UW, EC, and HOC, respectively
(Table 4).
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Fig. 5. Comparison of hyperosmolar citrate (HOC) against isomolar citrate (IOC) demonstrated only marginal protection when tissues had not
endured any prolonged cold ischemia (A). After 24 hours of cold ischemia (B), a significant reduction in cell swelling was seen if an isosmolar solution
was used (P < 0.05). An analysis of the requirement for MgSO4 in the solution showed that its exclusion had no effect on strophanthidin-induced
cell swelling after 0 hours of cold ischemia (C, P > 0.05). Similarly, after 24 hours of cold ischemia (D), the exclusion of MgSO4 in the solution
had no effect on strophanthidin-induced cell swelling (P > 0.05). The exchange of the citrate buffer for a phosphate buffer (E) did not show an
improvement after minimal cold ischemia, while replacing citrate with a phosphate buffer in HOC showed significant improvement if tubules had
been rendered cold ischemic for 24 hours (F, P < 0.05).
DISCUSSION
This study analyzed the effect of preservation solu-
tions and their core components on preventing cellular
edema. An isolated renal proximal tubule system was de-
veloped that reproducibly demonstrated the edematous
response of single tubules to cold and warm ischemia. Al-
though this model examined only one aspect of ischemic
injury, it is cellular edema that forms the principal lesion
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Fig. 6. By using the strophanthidin-based model, a comparison (A) of the commercially available solutions with a phosphate buffered sucrose
solution (PBS140) showed that cell swelling was minimized by either University of Wisconsin (UW) or PBS140 compared to Euro-Collins (EC)
and hyperosmolar citrate (HOC) at time 0 (P < 0.01). The effect of 24 hours of cold ischemia (B) showed that cell swelling was most effectively
prevented during a warm ischemic episode if PBS140 was used (P < 0.01). After 48 hours of cold ischemia (C), our data show prolonged protection
with PBS140 comparable with UW. Prolonged protection with PBS140 comparable with UW was also seen at 72 hours of cold ischemia (D).
leading to pathologic features of ischemically damaged
organs. For this reason the prime component of a preser-
vation solution is its impermeant, whose function is the
prevention of cell swelling. The nature of cell swelling
in this model was believed to be due to abrogation of
cell volume regulation. Maintenance of a constant cell
volume is dependent on the rate of solute influx being
equal to solute efflux. Biologic membranes are highly
permeable to water and so ionic disturbance in the in-
tracellular and extracellular fluid leads to osmotic move-
ment of water across the plasma membrane. In the con-
text of ischemic depletion of ATP, energy dependent
solute transporters such as the Na+/K+ATPase are no
longer able to regulate cell volume. An accumulation
of intracellular Na+ is followed by influx of anions to
maintain electroneutrality [25–27] and water follows os-
motically into the cell. The use of strophanthidin in our
system to block the Na+/K+ pump modeled the phys-
iologic response of tubules to starvation of ATP with
regard to cell volume control. The cell swelling that
was detected was reversible once strophanthidin was re-
moved from the perfusion solution, as tubules attempted
to regain cell volume control. The isolated tubule experi-
ments therefore putatively reflected cellular edema, and
since the experiments were conducted at 37◦C following
periods of cold preservation, the model system allowed
an analysis of tubule responses to both cold and warm
ischemia.
The usefulness of the isolated tubule experiments was
validated by the experimental data in this study that
showed that UW solution was more effective in prevent-
ing cellular edema than EC or HOC. UW solution is
regarded as the “gold standard” in organ preservation
solutions so these observations widely reflected other
work using whole organs [28], but this study provided
a novel physiologic analysis of the edema that forms the
principal source of preservation injury. The isolated per-
fused tubule system permitted a direct investigation of
the effects of alterations to preservation solutions that
might predict outcomes in whole organ transplants, and
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Fig. 7. Tubule cell volume after 0 to 72 hours of CIT and subsequent increases following warm ischemia are shown for tubules preserved in EC (A),
HOC (B), UW (C), and PBS140 (D). The data showed that PBS140 minimized tubule volume changes after both cold and warm ischemic periods,
providing evidence of reduced edema compared to the other solutions.
Table 3. Percentage change in cell volume during pump blockade with strophanthidin and upon reversal of pump blockade compared to the first
control period in physiologic saline (0 hour cold ischemic time)
Cell volume ql·mm−1
Test solution Physiologic salinePhysiologic saline
Test solutions Cell volume Cell volume % change Cell volume % change
PBS140 221 ± 16 196 ± 18 −11 243 ± 22 +10
UW 225 ± 16 185 ± 17 −18 244 ± 30 + 8
EC 282 ± 35 455 ± 18 +62 367 ± 46 +30
HOC 244 ± 14 257 ± 15 +5 332 ± 16 +36
Abbreviations are: PBS140, phosphate-buffered sucrose; UW, University of Wisconsin; EC, Euro-Collins; HOC, hyperosmolar citrate.
Table 4. Percentage change in cell volume during pump blockade with strophanthidin and upon reversal of pump blockade compared to the first
control period in physiological saline (72 hours cold ischemic time)
Cell volume ql·mm−1
Test solution Physiologic salinePhysiologic saline
Test solutions Cell volume Cell volume % change Cell volume % change
PBS140 323 ± 37 254 ± 22 −21 344 ± 45 +7
UW 325 ± 27 269 ± 16 −17 398 ± 29 +23
EC 291 ± 16 468 ± 28 +61 402 ± 18 +38
HOC 427 ± 45 465 ± 42 +9 534 ± 48 +25
Abbreviations are: PBS140, phosphate-buffered sucrose; UW, University of Wisconsin; EC, Euro-Collins; HOC, hyperosmolar citrate.
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provided an elegant method to potentially design the op-
timal platform for a preservation solution to reduce cel-
lular edema.
For a variety of reasons, transplant centers worldwide
have adopted alternatives to UW for renal preservation
that are accepted as less than optimal because of the
“gold standard” status ascribed to UW. By implication,
therefore, a higher degree of tissue injury possibly oc-
curs at the time of transplantation where alternatives to
UW are used. Delayed graft function and acute tubular
necrosis due to I/R injury have been linked to subsequent
acute rejection episodes [4, 5], the incidence of which is a
major predictor of chronic allograft nephropathy—itself
the most common cause of allograft failure. It is clear
therefore that improvements in preservation solutions
may have significant benefits for clinical transplantation
worldwide.
The specific analysis of the core components of preser-
vation solutions in this study highlighted not only the dif-
ferences between various solutions in current clinical use,
but also could be used to establish the constituents of an
optimized solution for improved organ preservation. This
study confirmed the beneficial effects of impermeants in
preventing cell swelling, and appeared to show that su-
crose could be as effective as the raffinose that is used
in UW. Indeed, cell swelling was reduced in the presence
of EC or HOC if their impermeants were changed to
sucrose from mannitol or glucose, respectively, demon-
strating that tubule cell impermeability to monosaccha-
rides is at best only partial, and is not sustained through
prolonged ischemia. The data in this study, therefore,
showed that the renal tubules were more impermeant to
sucrose. Unlike glucose, sucrose is not transported across
cell membranes, nor broken down by sucrase activity in
the nephron, and so remains in the extracellular space
under both hypothermic and normothermic conditions.
Therefore, sucrose is a more suitable impermeant agent
for use in organ preservation than glucose, which once
transported into cells by the Na+/glucose transporter may
be used as a substrate for anaerobic metabolism and fur-
ther contribute to the accumulation of toxic metabolites
during ischemia. In addition, our observations also sug-
gested that tubular cell membranes may become more
permeable to mannitol over prolonged periods of cold is-
chemia. The data demonstrated that the benefits in using
sucrose were even more apparent the longer the period
of cold ischemia.
Cell swelling was also reduced after a prolonged cold
and warm ischemic period if an isosmolar solution was
used instead of a hyperosmolar solution. In a previous
study, a comparison of hyperosmolar and isosmolar forms
of HOC showed better preservation of isolated perfused
rat kidneys using isosmolar solution [29]. In the current
study of isolated tubules, on return to physiologic saline,
an irreversible increase in tubule diameter was seen in
the 0 hour HOC group. A similar effect has been ob-
served during the investigation of cell volume regulation
during hypertonic shock [30]. During volume regulation
in hypertonic medium, intracellular Na+ and Cl− con-
centrations increase with no concurrent alteration in K+
concentration. This imbalance drives an influx of water
upon rapid exchange of medium. The data in this study
would suggest that cell volume after exposure to HOC
remains at this increased level, though the reason for this
is unclear. However, this could have important implica-
tions for the clinical use of hypertonic preservation solu-
tions such as HOC and EC; cell swelling triggered by
return to isotonic conditions from hypertonic storage
could be responsible for some post-ischemic tissue
damage.
This study also investigated the effect of exchanging
the buffer from citrate (HOC) to phosphate (HOPBM).
After 0 hours of preservation there was no significant
difference in tubule diameter. However, after 72 hours
of cold ischemia, tubule diameter in the HOC group was
greater than the HOPBM group. This parameter was not
significantly different when comparing the IOC group at
72 hours. Taken together, these findings suggest that cit-
rate is more permeable than phosphate, at least under
hypertonic conditions.
The direct comparison of solutions over 72 hours in-
dicated that cell volume during warm ischemia was es-
sentially uncontrolled in tubules preserved in EC, and
worsened with prolonged CIT in HOC. Upon reperfu-
sion with saline at the end of the experiment to remove
the preservation fluid under test, regulatory volume de-
crease (RVD) was repeatedly seen in the tubules exposed
to EC as they presumably recovered from the more se-
vere warm ischemic swelling induced in the presence of
glucose. Such RVD was not seen with the other solutions
that did not induce the same degree of swelling. How-
ever, the data shows that tubule diameter was lowest in
the PBS140 group at the end of the experimental proto-
col after 24, 48 or 72 hours of CIT, even when compared
to the performance of UW.
Our data clearly demonstrate the shortcomings of
HOC, as well as solutions that used a less effective im-
permeant, such as EC. These solutions have been used
widely in clinical transplantation but clearly there may
have been increased posttransplant complications as a re-
sult. Direct comparisons with the common preservation
solutions have been made in clinical and experimental
transplant studies and these have revealed that UW is
better than either EC or HOC.
However, the experimental analyses presented here
would suggest that an isosmolar, phosphate-buffered su-
crose solution such as PBS140 could form the basic plat-
form for an optimized renal preservation solution. Earlier
studies have hinted that this may be the case [31–33], but
this study is the first to definitively examine at the tubular
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level, the physiologic response of renal tissue to preser-
vation solutions. The data here suggest that phosphate-
buffered sucrose solutions have the potential to offer
better conditions for organ preservation than UW. In-
deed, in a previous trial of PBS140 in clinical renal trans-
plantation, improved results posttransplant were seen
[34]. The data presented here revealed that PBS140 pre-
vented cell swelling more effectively than UW in this ex-
perimental setting, and that warm ischemic cell swelling
after 72 hours of cold ischemia was reduced threefold by
PBS140, compared to UW-preserved tissue.
These observations could therefore have significant im-
plications for the clinical management of ischemic dam-
age. If PBS140 could reduce cell swelling more effectively
than UW, then by implication less tissue damage occurs in
PBS140 preserved tissues. This can be interpreted in two
ways: first, less tissue damage occurs in short (<24 hours)
cold ischemic times, and second, tissues remain more vi-
able for longer ischemic times. In addition, PBS140, being
a relatively simple solution, overcomes the shortcomings
of using UW. PBS140 has a lower viscosity, making its use
easier and permitting more rapid and efficient perfusion
of the donor organ. These factors all have the potential
to significantly improve transplant outcomes by reducing
the initial tissue damage at the time of transplantation.
This study, therefore, dissected the core components
of clinical preservation solutions and has proposed the
basis of an optimized preservation solution that may per-
form better than all other solutions currently in common
clinical practice. Further studies in whole organ and in
transplant systems are already underway. Any possible
benefit in switching from EC or HOC-based solutions
would probably be seen in reduced rates of acute tubular
nephropathy or in the incidence of DGF, but longer term
analysis of transplant recipients is required to demon-
strate the effectiveness of better organ preservation on
transplant outcome. The potential exists to reduce the
non-specific tissue injury that occurs in all donor organs
and to extend the possible pool of available organs.
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